证券记录 · 已归档季度
VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
19被追踪持有人
-3Δ持有人
200.96M持有股份
$2.50B报告持仓市值
+1新建仓位
−4清仓
动量输入（同类管理人）：
持有人广度 -13.6% ·
股份流向 +6.8% ·
净新建仓位 -15.8%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 63.75M | n/a | $793.65M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 58.68M | +20.3% | $730.56M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (被动) | 30.07M | +2.1% | $373.41M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 11.45M | +3.4% | $142.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 9.96M | +135.8% | $123.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Glenview Capital ✦ | 9.32M | +23.1% | $116.08M | 2.9% | ▲ Add | 3 | SEC ↗ |
| 7 | Greenlight Capital (DME Capital) ✦ | 5.79M | -20.4% | $72.02M | 3.7% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 3.77M | -38.8% | $46.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 2.29M | +71.4% | $28.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.88M | -13.3% | $23.47M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 11 | Gotham Asset Management ✦ | 1.52M | +14.6% | $18.92M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.17M | +2170.0% | $14.59M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 13 | Adage Capital Partners ✦ | 516.36K | 新增 | $6.43M | 0.0% | New | 1 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 303.12K | -3.5% | $3.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 162.60K | -67.6% | $2.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 133.62K | -82.7% | $1.66M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 17 | Capital World Investors ✦ | 110.68K | 0.0% | $1.38M | 0.0% | Held | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 68.15K | +10.1% | $848,442 | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 19 | Fisher Asset Management ✦ | 16.72K | +32.8% | $208,195 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $6.43M | 0.0% |
已清仓
| Arrowstreet Capital | $29.83M | 曾为 0.0% |
| Renaissance Technologies | $3.50M | 曾为 0.0% |
| Point72 Asset Management | $3.48M | 曾为 0.0% |
| Soros Fund Management | $118,828 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,011 持有人, 984.50M 股份, $12.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 08
SC 13G/A: FMR LLC
Aug 12
SC 13G/A: DAVIS SELECTED ADVISERS
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据